Home/Filings/4/0000899243-18-031912
4//SEC Filing

Pearce David B. 4

Accession 0000899243-18-031912

CIK 0000896262other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 9:01 PM ET

Size

6.3 KB

Accession

0000899243-18-031912

Insider Transaction Report

Form 4
Period: 2018-12-24
Pearce David B.
Chief Compliance Officer
Transactions
  • Sale

    Common Stock

    2018-12-24$106.61/sh410$43,71011,010 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    299
Footnotes (3)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
  • [F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.54 to $106.70, inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
  • [F3]The information in this report is based on a plan statement dated as of September 30, 2018.

Issuer

AMEDISYS INC

CIK 0000896262

Entity typeother

Related Parties

1
  • filerCIK 0001679089

Filing Metadata

Form type
4
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 9:01 PM ET
Size
6.3 KB